Compile Data Set for Download or QSAR
maximum 50k data
Found 13 Enz. Inhib. hit(s) with all data for entry = 9436
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466499(US10799605, Example 4)
Affinity DataIC50:  0.870nMAssay Description:In order to determine the binding affinity of compounds comprising a radiolabel for NTR1, a radioligand binding assay was carried out. A radioligand ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466500(US10799605, Example 5)
Affinity DataIC50:  2.90nMAssay Description:In order to determine the binding affinity of compounds comprising a radiolabel for NTR1, a radioligand binding assay was carried out. A radioligand ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466502(US10799605, Example 13)
Affinity DataIC50:  3nMAssay Description:In order to determine the binding affinity of compounds comprising a radiolabel for NTR1, a radioligand binding assay was carried out. A radioligand ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466505(US10799605, Example 19)
Affinity DataIC50:  3.40nMAssay Description:In order to determine the binding affinity of compounds comprising a radiolabel for NTR1, a radioligand binding assay was carried out. A radioligand ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466501(US10799605, Example 12)
Affinity DataIC50:  4.90nMAssay Description:In order to determine the binding affinity of compounds comprising a radiolabel for NTR1, a radioligand binding assay was carried out. A radioligand ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466504(US10799605, Example 18)
Affinity DataIC50:  5.30nMAssay Description:In order to determine the binding affinity of compounds comprising a radiolabel for NTR1, a radioligand binding assay was carried out. A radioligand ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466499(US10799605, Example 4)
Affinity DataIC50:  7.54nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466504(US10799605, Example 18)
Affinity DataIC50:  8.95nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466505(US10799605, Example 19)
Affinity DataIC50:  12.6nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466502(US10799605, Example 13)
Affinity DataIC50:  17.5nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466500(US10799605, Example 5)
Affinity DataIC50:  20nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466501(US10799605, Example 12)
Affinity DataIC50:  21.4nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466506(US10799605, Example 22)
Affinity DataIC50:  125nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent